The safety of cardioselective β(1)-blockers in asthma: literature review and search of global pharmacovigilance safety reports

INTRODUCTION: Beta-blockers are key in the management of cardiovascular diseases but blocking airway β(2)-receptors can cause severe and sometimes fatal bronchoconstriction in people with asthma. Although cardioselective β(1)-blockers may be safer than non-selective β-blockers, they remain relativel...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennett, Miriam, Chang, Catherina L., Tatley, Michael, Savage, Ruth, Hancox, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917232/
https://www.ncbi.nlm.nih.gov/pubmed/33681344
http://dx.doi.org/10.1183/23120541.00801-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917232/
https://www.ncbi.nlm.nih.gov/pubmed/33681344
http://dx.doi.org/10.1183/23120541.00801-2020

Ejemplares similares